Page 17 - 66_Neat

the brain.

This device can be implanted in a blood vessel that is placed on the motor cortex of the brain.
Implantation requires a less invasive procedure that involves making a small incision the size of
a keyhole in the neck. This is similar to placing a stent in the heart.
When the implant is in place, it expands to press the electrodes against the vessel wall near the
brain; Where it can record neural signals. These signals are transmitted directly from the brain to
the target areas in a unit that is implanted under the skin and in the chest. The signals are
transmitted through the electrode network and along the wire that connects it to the device in the
chest.

"The implanted unit in the chest is
programmed to receive signals from
the brain continuously, and because
it is connected to an external
receiver, it can send signals to a
computer," Syncron said of the
technology. Ultimately, this means
that the patient can control what is
on the computer screen. According
to the company, the Brain
Command Center connects directly
to the software, and the patient tries
to train his brain to directly control
the operating system.

The results of a synchronous SWITCH clinical trial unveiled last month at the American
Academy of Neurology show that the technology is safe in four patients.

The researchers monitored the participants for a year and found that the device was safe and had
no side effects that could lead to disability or death.

After stent implantation during the clinical trial of the switch, patients were able to use the
device without supervision and at home to send text messages, shop online and more.

The stent was previously implanted in two Australian men with amyotrophic lateral sclerosis
(ALS), a progressive disease of the nervous system, and the results were published in the 2020
issue of the Journal of NeuroInterventional Surgery.

Contents

Page 14